440.2500 -17.75 (-3.88%)
NSE Jan 23, 2026 15:31 PM
Volume: 211.8K
 

440.25
-3.88%
ICICI Securities Limited
Thyrocare’s Q2FY24 performance was in line with our expectations. Its revenue grew 9.7% YoY while the franchisee business grew faster at 20%. It reported an improvement in gross margins (+100bps YoY) due to a decline in the lowmargin Partnership business.
Promoters pledged 14.16% of shares in last quarter. Total pledge stands at 100.00% of promoter holdings
More from Thyrocare Technologies Ltd.
Recommended